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Summary
The contribution of T lymphocyte subpopulations to intrapulmonary and systemic resistance
against an opportunistic strain of Cryptococcus neoformans was examined . It was found that C .
neoformans was destroyed when introduced into the lungs of normal mice, but disseminated to
the brains of mice treated with an antibody that depleted them of CD4+ T cells. Depletion
of either CD8+ or CD4+ T cells impaired the ability of the host to clear the yeast from the
lung. These results, together with the observation that CD8+ T cells accumulate in the lungs
ofCD4+ T cell-deficient mice, suggest that CD8+ T cells play an important role in resistance
to C. neoformans infection acquired via the respiratory tract .
C
ryptococcus neoformans is one of the most commonly
encountered pathogens in AIDS patients (1) . Acquired
by inhaling basidiospores or desiccated yeast (2), C. neoformans
can disseminate from the lung to the central nervous system
(CNS), where it causes a life-threatening meningoencepha-
litis (1) . Even with aggressive chemotherapy, patient relapse
and mortality rates are high (3) . Thus, there is a strong mo-
tive to develop a vaccine or immunotherapy for this infec-
tion. However, before such immunotherapy can rationally
be developed, the mechanisms that function in resistance to
this yeast must be understood .
Several components of the host response to C. neoformans
have been identified and include T cell-mediated immunity
(reviewed in reference 4) . Of particular relevance to AIDS
are the recent findings ofMody et al . (5), that systemic dis-
ease caused by C. neoformans strain 145 is exacerbated in mice
treated with an antibody that depletes them of CD4+ T
cells. On the other hand, depletion ofCD4+ T cells had no
effect on the multiplication rate of this yeast at the site of
infection in the lung. However, virulent strains ofC. neoformans
are not true opportunistic pathogens in that they multiply
progressively in and kill normal immunocompetent hosts .
For this reason, a thinly encapsulated avirulent human iso-
late ofC . neoformans, which has been shown to cause non-
progressive infections when introduced into the lungs of
normal mice (6, 7), was chosen for this study.
It is shown that resistance against avirulent C . neoformans
is mediated by both CD4+ and CD8+ T cells. Whereas
CD4+ T cell-dependent mechanisms appear to prevent the
yeast from establishing metastatic foci in the brain, both
CD8+ and CD4+ T cells play a role in destruction of the
yeast at the primary site of infection in the lung.
Materials and Methods
Cryptococcus neoformans.
￿
Serotype A strain 184 (6) was kindly
provided byDr . Juneann Murphy ofthe University of Oklahoma
Health Sciences Center, Oklahoma City. Organisms in log-phase
growth at 37°C were harvested from Sabouraud's dextrose broth
by centrifugation, and washed in PBS . Yeast cells in the inoculum
were counted on a hemocytometer and suspended to 10'/ml . A
sample was plated on Sabouraud's agar to confirm the concentra-
tion of viable organisms.
BALB/c mice obtained from the Trudeau Institute Animal
Breeding Facility were infected intratracheally with 10 6 yeast cells
in 100 pl of PBS, as previously described (8) .
In Vivo Depletion ofT CellSubsets.
￿
The hybridoma GK1.5 (Dr.
Frank Fitch, University of Chicago) secreting rat IgG2b anti-L3T4
mAb, and hybridomas 30-H12 and TIB-210 (American Type Cul-
ture Collection, Rockville, MD) producing IgG2b antiThy-1 .2 and
anti-Ly-2.2 mAbs, respectively, were grown as ascites in pristane-
primed, irradiated BALB/c mice . The rat IgG2b content of ascites
was quantitated by ELISA, and the mAbs were stored at -70°C
until needed. To deplete T cells, mice were thymectomized at 4-5
wk of age and infused intravenously 1 wk later with 1 mg of the
appropriate mAb. One group of control mice received 1 mg of
normal, affinity-purified rat IgG (ICN Immunobiologicals, Lisle,
IL) . Mice were infected with C. neoformans 1 wk after mAb treat-
ment . Recipients ofanti-CD4mAb received an additional 0.5-mg
dose of mAb every 10 d (9) .
Cytofluorometry .
￿
The efficiency ofT cell depletions was deter-
mined by flow cytofluorometric analysis of cells obtained from the
lung by bronchoalveolar lavage. F(ab') z fragments of the anti-CD4,
anti-CD8, and antiThy-1.2 mAbs were prepared and conjugated
to fluorescein as described by Gutstein and Wofsy (10) . A cocktail
containing FITC-conjugated goat anti-mouse Ig G, A, andM was
obtained from Cappel Laboratories (West Chester, PA) .
Cells were incubated with the FITC-labeled reagents, and
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and analyzed with aFACScan® cytofluorometer (BectonDickinson
&Co., Sunnyvale, CA). Data are expressed as the mean number
of viable CD4 `, CD8 * , Thy-1.2 * , and Ig+ cells present .
Enumeration of ViableC . neoformans.
￿
At various times after in-
oculation, four mice from each experimental group were anesthe-
tized with halothane gas and exsanguinated . The tracheawas ex-
posed and intubated, and the lungs were lavaged with 5-1.0-ml
volumes of Cal+- and Mgt*-free HBSS supplemented with 3mM
EDTA (7).The cells in the lavage fluids were countedand differen-
tial counts were obtained from cytocentrifuge smears stained with
DifQuik (American Scientific Products, McGaw Park, IL).
The lung, liver, and brain were homogenized in ice-cold PBS
in thick-walled glass tubes fitted with Teflon pestles. The ho-
mogenates of these tissues were appropriately diluted in PBS, and
100-pl aliquots were placed onto Sabouraud's agar. After 24-48 h
of incubation, colonies of C . neoformans were enumerated .
Statistics.
￿
The number (logto) of viable C . neoformans (CFU)
in the tissues of infected mice are expressed as the mean (t SD)
of four or five mice. Sample means were compared with the Stu-
dent's t test . Each experiment was performed three times.
Results
Resistance to an Intratracheal Challenge with C . neoformans
in Mice Depleted ofCD4+ or CD8+ T Cells. BALB/c mice
were thymectomized and then treatedwith anti-CD4 mAb,
anti-CD8 mAb, or both mAbs. 1 wk later, these mice and
controls treated with normal rat IgG were infected in the
lung withC. neoformans . At 6wk of the infection, the mice
were killed and viable yeast cells in their lungs, livers, and
brains were enumerated . Results in Table 1 show that normal
BALB/c mice were resistant to the opportunistic 184 strain,
having eliminated allbut 100 of theyeast cells, with no dis-
semination of the infectionto extrapulmonary organs . Deple-
tion of CD8+ T cells and, to a lesser extent, depletion of
CD4+ T cells resulted in a significant increase in the number
of yeast cells at the site of infection in the lung. However,
only CD4+ T cell--depleted mice had disseminated disease,
as evidenced by the presence of 103-104 viable yeast cells in
their brains . Mice depleted of bothT cell subsets were not
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able to eliminatetheyeast from theprimary site of infection
in thelung, or to prevent it from establishing metastatic foci
of infection in the brain.
Kinetics of Growth ofC . neoformans in the Lungs of Mice
Depleted of CD4+ vs. CD8+ T Cells. The effects of de-
pletingT cell subsets on the pulmonary phase of thedisease
was examined by infecting mice intratracheally with 106
C. neoformans, and killing groups of infected mice at 1, 3,
and 7 d, and at weekly intervals thereafter. It can be seen
in Fig . 1 that elimination ofthe yeast from thelungsofnormal
mice began at3wk of the infection, andthenumber ofviable
yeast cells declined progressively thereafter. Fig . 1 also shows
that depleting CD4+ T cells had only a slight but signi-
ficant (p < 0.05) effect on the ability of the host to clear the
yeastfrom therespiratory tract, as evidencedby a1-wk delay
in the onset of elimination of the yeast. In contrast, mice
depleted of CD8+ T cells failed to eradicate the organism,
and acquired a chronic pulmonary infection. These and the
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Figure 1 .
￿
Fate of C . neoformans in the lungs of normal and T cell
subset-depletedBALB/c mice. Mice were thymectomized and infused in-
travenously with 1 mg of the appropriatemAb . Mce were infected in-
tratracheally with 106 C . neoformans 1 wk later. Recipients of anti-CD4
mAb received additional 0.5-mg doses ofmAb every 10 d . Each point
represents the mean (±SD) of four or five mice .
Table 1 .
￿
Number (logto) of Viable C . neoformans in the Lungs and Extrapulmonary Organs of Normal and T Cell-decent Mice
at 6 wk after Intratracheal Inoculation with 106 yeast cells
To deplete T cell subpopulations, groups of female BALB/c mice were thymectomized and treated in vivo with anti-CD4 mAb, anti-CD8 mAb,
or both mAbs . 1 wk after treatment, mice were inoculated intratracheally with C . neoformans. 6 wk later, the mice were killed and viable yeast
in the organs were enumerated by plating samples of homogenized tissue on SDA. Data are the mean (±SD) of four or five mice .
" Data from T cell-depleted mice are compared with rat IgG-treated controls with the Student's t test, with p < 0.05 considered statistically significant .
t Not significantly different from rat IgG-treated controls .
Treatment
Rat IgG
Lung
2.26 ± 0.56
Liver
<1.48
Brain
<1 .48
Anti-CD4 mAb 3.80 t 0.26 <0.001" 3 .78 ± 0.53 <0.05 2 .99 ± 0.67 <0.02
Anti-CD8 mAb 5 .06 t 0.26 <0.001 <1.48 NS# <1 .48 NSt
Anti-CD4 mAb +
anti-CD8 mAb 7.07 t 0.45 <0.001 5 .31 ± 0.61 <0.001 6.28 t 0.42 <0.001J
U
ANTI-CD8 mAb-TREATED
7
6
5
4
3
2
04
ANTI-CD4 mAb-TREATED
7
6
5
4
3
2
1
0
7
6
5
4
3
2
ANTI-CD4 and ANTI-CD8
mAb-TREATED
0 1 2 3 4, 5 6 0 1 2 3 4 5- 6
WEEK OF INFECTION
Figure 2 .
￿
Changes with time ofinfection in the lymphocyte composi-
tion of the alveolar exudate obtained by bronchopulmonary lavage from
the lungs of normal mice and mice treated with anti-CD4 mAb, anti-
CD8 mAb, or both mAbs . Results are from flow cytofluorometric anal-
yses of cells stained for Thy-1.2, CD4, andCD8 with FITC-conjugated
F(ab')2 fragments of the 30-H12, GK1 .5, and TIB-210 mAbs, respectively.
B cells were identified by staining with a cocktail containing a mixture
ofFITC-conjugated goat anti-mouse IgG, A, andM . Each point represents
the mean of four or five mice.
CD4+ T cell-depleted mice appeared healthy at 10 wk .
Mice depleted of both CD4+ and CD8+ T cells developed
a progressive disease andbecame moribundby 6wk . On death,
the lungs were hemorrhagic, and yeast cells were visible as
cyst-like aggregates beneath the pleura .
Changes in the Composition of the Alveolar Exudate during
the Expression ofAnti-Cryptococcus Immunity in the Respiratory
Tract. Microscopic examinations of lavage fluids of normal
mice revealed an initial increase inPMN during the first 24 h
after inoculation . The numbers ofPMN rapidly declined,
followed by an increase in macrophages and lymphocytes. As
the numbers of yeast cells decreased in the lungs of normal
mice, so did the numbers of mononuclear cells. A similar
pattern was observed in lavage fluids of mice depleted of ei-
ther CD4+ or CI38+ T cells .
Fig. 2 shows the changes, against time of infection, in the
lymphocyte populations in the lungs of normal and T
cell-deficient mice. It can be seen that most of the lympho-
cytes that accumulated in the alveoli of normal mice were
CD4+, with smaller numbers ofCD8+ T cells also present .
T cells targeted for depletion withmAb were completely ab-
sent from the alveolar exudate . Although some Thy-1.2+
cells were found in the lungs of doubly depleted mice, it is
almost certain that they were neither CD4+ nor CD8+ .
Their surface membrane phenotype was not characterized any
further. It is important to note, however, that mice treated
with anti-CD4 mAb or anti-CD8 mAb had numbers ofThy-
1.2+ cells in their alveolar exudate comparable with that in
normal controls . This indicates that there had been an ex-
pansion in the undepleted T cell subset in the lung .
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This paper provides evidence that CD8+ as well as CD4+
T cells are involved in protective immunity against an op-
portunistic strain of C. neoformans . It shows that CD8+ T
cells are important for the protectiveimmune response at the
site of infection of the lung, whereas CD4+ T cells appear
to be more important for preventing the dissemination of
the disease to the brain and other extrapulmonary sites. Thus,
the results parallel those published byMody et al. (5), which
showed that in mice infected with a highly virulent strain
of C. neoformans, a deficiency in CD4+ T cells increases the
risk of cryptococcal meningoencephalitis by allowing the es-
tablishment of metastatic foci of infection in the brain .
It is perhaps significant that while CNS infections caused
byC. neoformans are a formidable clinical problem, the pneu-
monia that may precede or accompany meningoencephalitis
in AIDS patients is often mild or asymptomatic (11, 12) . One
could suggest that their possession of a significant number
of CD8+ T cells is the reason whyAIDS patients fail to de-
velop progressive pulmonary disease. Our studies in mice
clearly show that the generation and the expression of pro-
tective CD8+ T cell-mediated anti-Cryptococcus immunity
in the lung can occur in the virtual absence of CD4+ T
cells .
After recruitment to the lung (13), protective CD8+ T
cells, or their precursors, undoubtedly undergo considerable
expansion in the respiratory tract, as evidenced by the finding
that the number of T cells in the lungs of CD4+ T
cell-depleted mice was comparable with the number in in-
fected control mice. It should be noted that expansion of
the number ofCD8+ (OKT8+) T cells has also been docu-
mented in the lungs and peripheral blood in AIDS patients
(12, 14, 15) . However, because of the generally accepted be-
lief that suppressor T cells can be CD8+, it has been as-
sumed by some that these CD8+ T cells were interfering
with a protectiveimmune response (12, 14, 16) . Our results
in mice illustrate, however, that CD8+ T cells can con-
tribute to, rather than suppress, protective immunity in the
CD4+ T cell-depleted host .
How CD8+ T cells function in anti-Cryptococcus immu-
nity and why these cells apparently cannot completely pre-
vent the dissemination of the yeast to extrapulmonary sites
remains to be determined. Although it is now well docu-
mented that CD8+ T cells can carry out functions previ-
ously thought to be performed exclusively by CD4+ T cells
(17, 18), it is possible that some yeast cells escape the lung
before a therapeutic level of CD8+ T cell-mediated immu-
nity is generated and focused. It is also possible that immune
mechanisms mediated by CD8+ T cells are not expressed on
a systemic basis and thus may be ineffective against organisms
that gain access to the circulation . Nonetheless, our results
join an increasing body of evidence that shows that immu-
nity against nonviral infections (19-22), including another
opportunistic pathogen, Toxoplasma (23), can depend on
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